Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.
about
CIViC databasePrimary and acquired resistance to biologic therapies in gastrointestinal cancers.Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition.Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancerFeedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells.Combination Adjuvant Chemotherapy with Targeted Drugs for Treatment of Colorectal Cancer: A Network Meta-Analysis.Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer.On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer: a systematic review with meta-analysis.Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients.Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.Current and future biomarkers in colorectal cancer.Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer.Hypomagnesemia and clinical benefits of anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer: a systematic review and meta-analysis.Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer.
P2860
Q27612411-E7D8F592-8C63-4A78-958F-2A01D7A79B96Q33895573-C4D92CAF-5AF5-4315-92FD-615577B97637Q34526499-D493CD92-5DBE-42CE-8E60-97FA36F50082Q36115580-C708E816-AB07-498C-861C-C7FBA95EEF23Q37146300-BE3BE3CD-0E27-4DA4-AEE8-3133C2F9A634Q37706176-4E8B4D3B-91AC-47AE-9440-223F80FB91E1Q38644154-EA4C4BE2-00D3-455D-9745-68A0E7B66C34Q38805790-585DB62E-1424-433C-8090-E428FA5C249CQ39017641-BE43553C-0A9A-400C-9776-54F13B7A3AFFQ39703372-AA2C8675-1319-4E97-B1F3-CDEBF7A7B2CAQ42317498-C3784126-7A76-42DC-B5C5-700BBCE698E5Q42696314-D58B2A15-AC96-423A-97C1-821D0C0CE038Q43492228-768AF1A7-573E-4D9B-8924-B1850D19B0C9Q47163641-4986191E-A42D-46A8-8FAA-F8E1AE296885Q47168309-AF9F2A90-FCE5-4DF9-9BE7-5F8965884F54Q47698425-22863828-5734-4CF7-8CC8-5B2182BB97E1Q47707557-FC7523AC-2D51-4767-9BD5-626650CA9CDCQ52666988-74A81C6D-DE69-4B70-AC1E-D236B0C26CDBQ55003485-3FEBE031-8714-4FAF-8A2C-0585165A5B8D
P2860
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@ast
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en-gb
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@nl
type
label
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@ast
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en-gb
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@nl
prefLabel
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@ast
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en-gb
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@nl
P2093
P50
P6366
P1154
2-s2.0-85010657777
P1433
P1476
Combined Epiregulin and Amphir ...... pe Advanced Colorectal Cancer.
@en
P2093
Faye Elliott
Gemma Hemmings
Jenny F Seligmann
Matthew T Seymour
P356
10.1001/JAMAONCOL.2015.6065
P5530
P577
2016-02-11T00:00:00Z
P6179
1029028484
P6366
2273698479